Risk factors and long-term evolution of thyroid dysfunction during repeated antiviral treatments in 221 patients with chronic hepatitis C

被引：0
作者：
Moncoucy, X
Leymarie, F
Levy, S
Bernard-Chabert, B
Jolly, D
Delemer, B
Cadiot, G
Diebold, MD
Thiefin, G
机构：
来源：
GASTROENTEROLOGY | 2004年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A431 / A431
页数：1
相关论文
共 50 条
  • [31] Impact of steatosis on long-term histological outcome in chronic hepatitis C after antiviral therapy
    Hung, Chao-Hung
    Kuo, Fang-Ying
    Wang, Jing-Houng
    Lu, Sheng-Nan
    Hu, Tsung-Hui
    Chen, Chien-Hung
    Lee, Chuan-Mo
    Eng, Hock-Liew
    ANTIVIRAL THERAPY, 2006, 11 (04) : 483 - 489
  • [32] Reversible autonomic dysfunction during antiviral treatment in patients with chronic hepatitis C virus infection
    Osztovits, Janos
    Horvath, Evelin
    Tax, Judit
    Csihi, Levente
    Horvath, Tamas
    Littvay, Levente
    Toth, Tamas
    Abonyi, Margit
    Lakatos, Peter L.
    Kollai, Mark
    Feher, Janos
    Szalay, Ferenc
    Blum, Hubert E.
    HEPATITIS MONTHLY, 2011, 11 (02) : 114 - 118
  • [33] Long-Term Outcome of Renal Transplant Recipients With Chronic Hepatitis B Infection-Impact of Antiviral Treatments
    Yap, Desmond Y. H.
    Tang, Colin S. O.
    Yung, Susan
    Choy, Bo Ying
    Yuen, Man Fung
    Chan, Tak Mao
    TRANSPLANTATION, 2010, 90 (03) : 325 - 330
  • [34] LONG-TERM SAFETY AND EFFICACY OF MIRAVIRSEN IN CHRONIC HEPATITIS C PATIENTS
    van der Ree, M. H.
    van der Meer, A. J.
    de Bruijne, J.
    van Vliet, A.
    Welzel, T. M.
    Lawitz, E. J.
    Rodrigues-Torres, M.
    Kupcova, V.
    Wiercinska-Drapalo, A.
    Hodges, M. R.
    Janssen, H. L. A.
    Reesink, H. W.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S443 - S443
  • [35] Long-term persistence of anti-rods and rings antibodies in patients with chronic hepatitis C after antiviral treatment
    Ana Beatriz da Silva Sacerdote
    Norma Arteiro Filgueira
    Silvana de Barros Barreto
    Andréa Dória Batista
    Edmundo Pessoa Lopes
    Immunologic Research, 2018, 66 : 605 - 610
  • [36] Long-term follow-up-of chronic hepatitis C patients non-responders to antiviral treatment.
    Galeras, JA
    Cirera, I
    Coll, S
    Marquez, C
    Gimenez, MD
    Bory, F
    Sola, R
    HEPATOLOGY, 2003, 38 (04) : 442A - 442A
  • [37] Can Transient Elastography Predict Fibrosis Regression in Patients with Chronic Hepatitis B During Long-Term Antiviral Therapy?
    Huang, Rui
    Yan, Xiaomin
    Liu, Yong
    Zhang, Zhaoping
    Wu, Chao
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (09) : 1477 - 1478
  • [38] Characteristics and risk factors of thyroid dysfunction following interferon therapy in patients with chronic viral hepatitis
    桂红莲
    ChinaMedicalAbstracts(InternalMedicine), 2013, 30 (02) : 71 - 72
  • [39] Analysis of background factors influencing long-term prognosis of patients with chronic hepatitis C treated with interferon
    Yoneyama, K
    Yamaguchi, M
    Kiuchi, Y
    Morizane, T
    Shibata, M
    Mitamura, K
    INTERVIROLOGY, 2002, 45 (01) : 11 - 19
  • [40] Positive impact of antiviral therapy on the long term outcome of chronic hepatitis C patients with cirrhosis
    Cardoso, Ana C.
    Moucari, Rami
    Boyer, Nathalie
    Asselah, Tarik
    Laatar, Asma
    Ripault, Marie-Pierre
    Martinot-Peignoux, Michele
    Maylin, Sarah
    Bedossa, Pierre
    Marcellin, Patrick
    HEPATOLOGY, 2007, 46 (04) : 346A - 346A
12345